Selective Lymphopenia and Opportunistic Infections in Neuroendocrine Tumor Patients Receiving Temozolomide

REFERENCES

• Middleton M. R., Grob J. J., Aaronson N., Fierlbeck G., Tilgen W., et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J. Clin. Oncol. 2000; 18(1)158–166
   PubMed Web of Science ®Google Scholar
• Korones D. N., Benita-Weiss M., Coyle T. E., Mechtler L., Bushunow P., et al. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. Cancer 2003; 97(8)1963–1968
   PubMed Web of Science ®Google Scholar
• Su Y. B., Sohn S., Krown S. E., Livingston P. O., Wolchok J. D., et al. Selective CD4 + lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J. Clin. Oncol. 2004; 22(4)610–616
   PubMed Web of Science ®Google Scholar
• Kulke M. H., Ryan D. P., Stuart K., Morgan J. A., Clark J. W., et al. Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J. Clin. Oncol. 2006; 24(3)401–406
   PubMed Web of Science ®Google Scholar
• Brock C. S., Newlands E. S., Wedge S. R., Bower M., Evans H., et al. Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res. 1998; 58(19)4363–4367
   PubMed Web of Science ®Google Scholar
• Poplin E. A., Gordon C. J., Piskorowski T. J., Chandrasekar P. H. Pneumocystis carinii pneumonia in patients with solid tumors without acquired immune deficiency syndrome. Cancer 1991; 68(1)193–194
   PubMed Web of Science ®Google Scholar
• Kulke M. H., Vance E. A. Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin. Infect. Dis. 1997; 25(2)215–218
   PubMed Web of Science ®Google Scholar
• Sepkowitz K. A. Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin. Respir. Infect. 1992; 7(2)114–121
   PubMedGoogle Scholar
• Sepkowitz K. A., Brown A. E., Telzak E. E., Gottlieb S., Armstrong D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992; 267(6)832–837
   PubMed Web of Science ®Google Scholar
• Zahar J. R., Robin M., Azoulay E., Fieux F., Nitenberg G., Schlemmer B. Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin. Infect. Dis. 2002; 35(8)929–934
   PubMed Web of Science ®Google Scholar
• Gnann J. W., Jr., Whitley R. J. Clinical practice. Herpes zoster. N. Engl. J. Med. 2002; 347(5)340–346
   PubMed Web of Science ®Google Scholar
• Gnann J. W., Jr. Varicella-zoster virus: atypical presentations and unusual complications. J. Infect. Dis. 2002; 186: S91–S98, (Suppl. 1)
   PubMed Web of Science ®Google Scholar
• Locksley R. M., Flournoy N., Sullivan K. M., Meyers J. D. Infection with varicella-zoster virus after marrow transplantation. J. Infect. Dis. 1985; 152(6)1172–1181
   PubMed Web of Science ®Google Scholar
• Landolfo S., Gariglio M., Gribaudo G., Lembo D. The human cytomegalovirus. Pharmacol. Ther. 2003; 98(3)269–297
   PubMed Web of Science ®Google Scholar
• Matthes T., Kaiser L., Weber D., Kurt A. M., Dietrich P. Y. Cytomegalovirus colitis—a severe complication after standard chemotherapy. Acta Oncol. 2002; 41(7–8)704–706
   PubMed Web of Science ®Google Scholar
• Sepkowitz K. A. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin. Infect. Dis. 2002; 34(8)1098–1107
   PubMed Web of Science ®Google Scholar
• Chang S. M., Prados M. D., Yung W. K., Fine H., Junck L., Greenberg H., et al. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer 2004; 100(8)1712–1716
   PubMed Web of Science ®Google Scholar
• Stupp R., Dietrich P. Y., Ostermann Kraljevic S., Pica A., Maillard I., et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J. Clin. Oncol. 2002; 20(5)1375–1382
   PubMed Web of Science ®Google Scholar
• Hwu W. J., Krown S. E., Menell J. H., Panageas K. S., Merrell J., et al. Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma. J. Clin. Oncol. 2003; 21(17)3351–3356
   PubMed Web of Science ®Google Scholar
• Fulkerson W. J., Newman J. H. Endogenous Cushing's syndrome complicated by Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 1984; 129(1)188–189
   PubMed Web of Science ®Google Scholar
• Kim D. S., Park S. K., Choi W. H., Kim T. W., Choi Y. Y., et al. Pneumocystis carinii pneumonia associated with a rapid reduction of cortisol level in a patient with ectopic ACTH syndrome treated by octreotide and ketoconazole. Exp. Clin. Endocrinol. Diabetes 2000; 108(2)146–150
   PubMed Web of Science ®Google Scholar
• Natale R. B., Yagoda A., Brown A., Singer C., Stover D., Bajorunas D. Combined Pneumocystis carinii and Nocardia asteroides pneumonitis in a patient with an ACTH-producing carcinoid. Cancer 1981; 47(12)2933–2935
   PubMed Web of Science ®Google Scholar
• Arend S. M., Kroon F. P., van't Wout J. W. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. an analysis of 78 cases. Arch. Intern. Med. 1995; 155(22)2436–2441
   PubMed Web of Science ®Google Scholar
• Russian D. A., Levine S. J. Pneumocystis carinii pneumonia in patients without HIV infection. Am. J. Med. Sci. 2001; 321(1)56–65
   PubMed Web of Science ®Google Scholar
• Varthalitis I., Aoun M., Daneau D., Meunier F. Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence. Cancer 1993; 71(2)481–485
   Google Scholar
• Mansharamani N. G., Garland R., Delaney D., Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000; 118(3)704–711
   PubMed Web of Science ®Google Scholar
• Kovacs J. A., Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N. Engl. J. Med. 2000; 342(19)1416–1429
   PubMed Web of Science ®Google Scholar
• Einsele H., Ehninger G., Hebart H., Wittkowski K. M., Schuler U., et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995; 86(7)2815–2820
   PubMed Web of Science ®Google Scholar
• Peggs K. S., Preiser W., Kottaridis P. D., McKeag N., Brink N. S., et al. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation. Br. J. Haematol. 2000; 111(3)782–790
   PubMed Web of Science ®Google Scholar
• Mansharamani N. G., Balachandran D., Vernovsky I., Garland R., Koziel H. Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000; 118(3)712–720
   PubMed Web of Science ®Google Scholar